Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
about
Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoproteinPotential contribution of aromatase inhibition to the effects of nicotine and related compounds on the brainAdvances in device and formulation technologies for pulmonary drug delivery.Loxapine inhalation powder (adasuve): a new and innovative formulation of an antipsychotic treatment for agitation.Addressing the need for rapid treatment of agitation in schizophrenia and bipolar disorder: focus on inhaled loxapine as an alternative to injectable agents.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.Loxapine inhalation powder: a review of its use in the acute treatment of agitation in patients with bipolar disorder or schizophrenia.The effect of the medicine administration route on health-related quality of life: Results from a time trade-off survey in patients with bipolar disorder or schizophrenia in 2 Nordic countries.A randomized, placebo-controlled repeat-dose thorough QT study of inhaled loxapine in healthy volunteersRationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI.The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical ReviewAlternative delivery systems for agents to treat acute agitation: progress to date.The psychopharmacology of violence: making sensible decisions.Revisiting loxapine: a systematic review.Assessment and management of agitation in psychiatry: Expert consensus.Inhaled loxapine and intramuscular lorazepam in healthy volunteers: a randomized placebo-controlled drug-drug interaction study.Pharmacokinetics and Safety of Single-Dose Inhaled Loxapine in Children and Adolescents.Patient preferences for medicine administration for acute agitation: results from an internet-based survey of patients diagnosed with bipolar disorder or schizophrenia in two Nordic countries.Pharmacological treatment of acute agitation associated with psychotic and bipolar disorder: a systematic review and meta-analysis.Clinical Trial Simulations and Pharmacometric Analysis in Pediatrics: Application to Inhaled Loxapine in Children and Adolescents.Inhaled Loxapine for Agitation in Intoxicated Patients: A Case Series.[Inhalative loxapine: old tried and trusted medication with new indications].Safety and efficacy of self-administered inhaled loxapine (ADASUVE) in agitated patients outside the hospital setting: protocol for a phase IV, single-arm, open-label trial
P2860
Q27333881-C292D859-B183-4224-A3B3-56D1C535B2CEQ28714245-B8BA4CF4-30A0-4E34-AA60-2F7CE7372BEBQ33962567-7A67A73D-0041-4893-9C31-79756370C3E6Q34154957-F0D58650-9A8E-4384-AC0A-02F6A4F4272CQ34347796-2DB953D7-3315-432C-8EC6-0166EC79883CQ34640811-BDAFCD71-FF07-4181-B7FA-2E3603D2FA37Q34652719-E0254600-3D58-456C-98E4-AABE3DE71AAAQ36078953-ABC0E7D2-F754-4FAD-BC41-34D5FE2F0718Q36177817-2D325BB8-5C92-4BB8-9F09-F3D0E85C9F84Q36334957-6124AE8C-8B78-49CD-B2F0-760C143B2B57Q37653402-603EBBB9-BE1E-4059-B140-9ACB11707C3BQ37690847-E65AB558-AF48-4BE8-B27E-B95CB5760DCFQ38154852-3B6F9B50-C38A-4A26-945C-DF7C269D68B6Q38191300-E2897304-3F4D-4A6B-95A0-E095E3B2D27CQ38413932-D859B5D2-5132-4284-8664-6DD65D6BFEFBQ38749001-860BD80B-ECEF-489B-8672-D2E14E397FACQ38761946-D468C2D2-634B-44F3-8AC9-7A17800C4A99Q38782957-B9A7A62B-C433-439B-8F83-EF2EE21BE554Q38802344-D83D1E71-F98E-4D09-9D1E-8F375ADBD777Q38827227-ADDCDB13-F419-4E6D-A581-FA90441E128CQ38958562-C0F25DBA-9E15-479A-AD59-A42FE38285ABQ42697689-1DE048F4-D889-45A7-82D8-1E979456A14DQ44006378-21AC5C78-0EFC-436D-A087-EE5BFB013A57Q57044328-43EDAB80-BBC5-4CFA-9CB9-4EFF8E2E80BF
P2860
Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Efficacy and safety of loxapin ...... ind, placebo-controlled trial.
@en
type
label
Efficacy and safety of loxapin ...... ind, placebo-controlled trial.
@en
prefLabel
Efficacy and safety of loxapin ...... ind, placebo-controlled trial.
@en
P2093
P356
P1476
Efficacy and safety of loxapin ...... ind, placebo-controlled trial.
@en
P2093
Daniel A Spyker
Daniel L Zimbroff
David Feifel
James V Cassella
Michael D Lesem
Michael H Allen
Patrik Munzar
P304
P356
10.4088/JCP.10M06011YEL
P577
2011-10-01T00:00:00Z